Is Covetrus, Inc. (CVET)’s Fuel Running Low? The Stock Just Declined Again

The stock of Covetrus, Inc. (NASDAQ:CVET) is a huge mover today! The stock decreased 4.02% or $0.58 during the last trading session, reaching $13.86. About 717,933 shares traded. Covetrus, Inc. (NASDAQ:CVET) has 0.00% since September 13, 2018 and is . It has by 0.00% the S&P500.
The move comes after 6 months negative chart setup for the $1.50B company. It was reported on Sep, 13 by We have $12.61 PT which if reached, will make NASDAQ:CVET worth $134.64M less.

Analysts await Covetrus, Inc. (NASDAQ:CVET) to report earnings on November, 12. CVET’s profit will be $9.71M for 38.50 P/E if the $0.09 EPS becomes a reality. After $0.12 actual earnings per share reported by Covetrus, Inc. for the previous quarter, Wall Street now forecasts -25.00 % negative EPS growth.

Covetrus, Inc. (NASDAQ:CVET) Ratings Coverage

Among 2 analysts covering Covetrus (NASDAQ:CVET), 1 have Buy rating, 1 Sell and 0 Hold. Therefore 50% are positive. Covetrus has $2100 highest and $1100 lowest target. $16’s average target is 15.44% above currents $13.86 stock price. Covetrus had 4 analyst reports since April 4, 2019 according to SRatingsIntel. On Thursday, August 15 the stock rating was maintained by Raymond James with “Outperform”.

More notable recent Covetrus, Inc. (NASDAQ:CVET) news were published by: which released: “46 Stocks Moving In Thursday’s Mid-Day Session – Benzinga” on August 15, 2019, also with their article: “Hedge Funds Have Never Been This Bullish On Covetrus, Inc. (CVET) – Yahoo Finance” published on June 19, 2019, published: “Covetrus Announces Second Quarter 2019 Earnings Release Date and Conference Call Information – Nasdaq” on July 30, 2019. More interesting news about Covetrus, Inc. (NASDAQ:CVET) were released by: and their article: “Covetrus Announces Financial Results for Second Quarter of 2019 – GlobeNewswire” published on August 13, 2019 as well as‘s news article titled: “12 Technology Stocks Moving In Monday’s Pre-Market Session – Benzinga” with publication date: September 09, 2019.

Covetrus, Inc. operates as an animal-health technology and services company. The company has market cap of $1.50 billion. The firm engages in the distribution of pharmaceuticals, nutrition products, consumable products, diagnostic tests, small and large equipment, laboratory products, surgical products, and others. It has a 46.23 P/E ratio. It also develops, sells, and distributes practice management software systems and computer hardware for animal health customers, as well as offers software support, data driven applications, training and education, client communication services, and value-added services.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.